Authors:
STRAUCH AR
COGAN JG
SUBRAMANIAN SV
ARMSTRONG ATA
SUN SQ
KELM RJ
GETZ MJ
Citation: Ar. Strauch et al., TRANSCRIPTIONAL ACTIVITY OF THE VASCULAR ALPHA-ACTIN GENE AS AN INDICATOR OF CELLULAR INJURY FOLLOWING CARDIAC TRANSPLANT, Transplant immunology, 5(4), 1997, pp. 261-266
Citation: Rj. Kelm et al., SEQUENCE OF CDNAS ENCODING COMPONENTS OF VASCULAR ACTIN SINGLE-STRANDED DNA-BINDING FACTOR-2 ESTABLISH IDENTITY TO PUR-ALPHA AND PUR-BETA, The Journal of biological chemistry, 272(42), 1997, pp. 26727-26733
Citation: Rj. Kelm et al., POLYPEPTIDE COMPOSITION OF THE VASCULAR ACTIN SINGLE-STRANDED-DNA BINDING-FACTOR-2 REPRESSOR COMPLEX, Molecular biology of the cell, 7, 1996, pp. 2711-2711
Citation: Rj. Kelm et al., REPRESSION OF TRANSCRIPTIONAL ENHANCER FACTOR-I AND ACTIVATOR PROTEIN-1-DEPENDENT ENHANCER ACTIVITY BY VASCULAR ACTIN SINGLE-STRANDED-DNA BINDING-FACTOR-2, The Journal of biological chemistry, 271(39), 1996, pp. 24278-24285
Citation: Rj. Kelm et al., OSTEONECTIN IN MATRIX REMODELING - A PLASMINOGEN-OSTEONECTIN-COLLAGENCOMPLEX, The Journal of biological chemistry, 269(48), 1994, pp. 30147-30153
Citation: Ma. Shatos et al., PLATELET OSTEONECTIN REGULATES FIBRINOLYTIC PROPERTIES OF HUMAN-CELLSIN-VITRO, Thrombosis and haemostasis, 69(6), 1993, pp. 1233-1233